Drug Type Small molecule drug |
Synonyms |
Action inhibitors |
Mechanism 5α-reductase inhibitors(Steroid 5 alpha reductase inhibitors), APE1 inhibitors(DNA-(apurinic or apyrimidinic site) lyase inhibitors), CYP17A1 inhibitors(Steroid 17-alpha-hydroxylase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Discovery | United States | - | |
| Prostatic Cancer | Discovery | United States | - |





